Endovia Health Sciences EDVA
NYSE EDVA
$0.26 +0.00 (+0.00%)
As of: Sep 3, 2026 · 11:52 AM EDT

Endovia Health Sciences (EDVA) Other financing activities (2019 - 2023)

Analysis

Endovia Health Sciences (EDVA) Other financing activities (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.50 Bn 133.65 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn
3 Argenx Se 65.05 Bn 59.86 Bn 1.37 Bn
4 Moderna 57.11 Bn 51.98 Bn 52.00 Mn
5 Revolution Medicines 44.71 Bn 44.71 Bn -
6 BeOne Medicines 40.40 Bn 35.31 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.36 Bn 32.05 Bn 992.69 Mn
8 Royalty Pharma 28.16 Bn 27.32 Bn -
9 Insmed 27.40 Bn 26.24 Bn 358.27 Mn
10 Endovia Health Sciences 801,166.21 558,464.21 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -78.00
Dec 31, 2022 -39.00
Sep 30, 2022 45,423.00
Jun 30, 2022 111,834.00
Mar 31, 2022 124,378.00
Dec 31, 2021 -253,200.00
Dec 31, 2020 -27,361.00
Sep 30, 2020 35,277.00
Jun 30, 2020 -39,641.00
Mar 31, 2020 190.00
Dec 31, 2019 -19,500.00
Sep 30, 2019 30.00
Jun 30, 2019 -1,044.00
Mar 31, 2019 1.00